Bristol-Myers Squibb Company Ce
Status: Publicly traded
Direct answer
Bristol-Myers Squibb Company Ce is publicly traded on NYSE under the ticker CELG-RI.
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell...
Can you invest in Bristol-Myers Squibb Company Ce?
Yes. Bristol-Myers Squibb Company Ce is publicly traded on NYSE under the ticker CELG-RI.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Bristol-Myers Squibb Company Ce
Detailed equity research is provided by MarketSnap.